CR20220517A - Materials and methods for binding siglec-3/cd33 - Google Patents

Materials and methods for binding siglec-3/cd33

Info

Publication number
CR20220517A
CR20220517A CR20220517A CR20220517A CR20220517A CR 20220517 A CR20220517 A CR 20220517A CR 20220517 A CR20220517 A CR 20220517A CR 20220517 A CR20220517 A CR 20220517A CR 20220517 A CR20220517 A CR 20220517A
Authority
CR
Costa Rica
Prior art keywords
methods
materials
binding
antigen
binding siglec
Prior art date
Application number
CR20220517A
Other languages
Spanish (es)
Inventor
Mehabaw Getahun Derebe
Sathyadevi Venkataramani
Sanjaya Singh
Karla R Wiehagen
Patrick John Doonan
Rajkumar Ganesan
Lqbal S Grewal
Original Assignee
Janssen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2021/052121 external-priority patent/WO2021181366A1/en
Application filed by Janssen Biotech Inc filed Critical Janssen Biotech Inc
Publication of CR20220517A publication Critical patent/CR20220517A/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La invención proporciona dominios de unión a antígeno que se unen a la proteína CD33 del antígeno de la superficie de células mieloides que comprende los dominios de unión a antígeno que se unen a CD33, polinucleótidos que los codifican, vectores, células huésped, métodos para fabricarlos y usarlos.The invention provides antigen-binding domains that bind to myeloid cell surface antigen CD33 protein comprising CD33-binding antigen-binding domains, polynucleotides encoding them, vectors, host cells, methods of making them and use them.

CR20220517A 2020-03-13 2022-03-15 Materials and methods for binding siglec-3/cd33 CR20220517A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US202062989071P 2020-03-13 2020-03-13
US202062989093P 2020-03-13 2020-03-13
US202062989120P 2020-03-13 2020-03-13
US202062989230P 2020-03-13 2020-03-13
US202162989187P 2021-03-13 2021-03-13
PCT/IB2021/052121 WO2021181366A1 (en) 2020-03-13 2021-03-15 Materials and methods for binding siglec-3/cd33

Publications (1)

Publication Number Publication Date
CR20220517A true CR20220517A (en) 2022-12-06

Family

ID=85724499

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20220517A CR20220517A (en) 2020-03-13 2022-03-15 Materials and methods for binding siglec-3/cd33

Country Status (1)

Country Link
CR (1) CR20220517A (en)

Similar Documents

Publication Publication Date Title
ECSP20082991A (en) BINDING AGENTS OF PSMA AND USES OF THEM
CL2018002490A1 (en) Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies that specifically bind to cd3 and / or cd123. (divisional application 201701866)
AR116718A1 (en) ANTI-CD38, ANTI-CD28 AND ANTI-CD3 TRIESPECIFIC BINDING PROTEINS AND METHODS OF USE TO TREAT VIRAL INFECTION
UY37340A (en) GPRC5D ANTIANTICBODIES, BIO-SPECIFIC ANTIGEN BINDING MOLECULES THAT JOIN GPRC5D AND CD3, AND USES OF THESE
BR112019000431A2 (en) antibodies against tim3 and their uses
CO2018010475A2 (en) Bcma binding molecules and methods of use thereof
PE20181013A1 (en) BISPECIFIC ANTIBODY CONSTRUCTS THAT BIND EGFRVIII AND CD3
CL2020003416A1 (en) Bispecific antibody constructs that bind mesothelin and cd3 (divisional sol. 201800268)
UY36974A (en) ANTI-IL1RAP ANTIBODIES, BINDING SPECIFIC MOLECULES THAT JOIN IL1RAP AND CD3, AND USES OF THESE
CO2021004534A2 (en) Trispecific anti-cd38, anti-cd28, and anti-cd3 binding proteins and methods of use to treat a viral infection
AR115422A1 (en) ANTI-CD3 ANTIBODIES AND USES OF THEM
CO2019001367A2 (en) Bispecific antibody type binding proteins that specifically bind to cd3 and cd123
CO2020000214A2 (en) Agonist antibodies that bind to human cd137 and their uses
EA201792572A1 (en) ANTIBODIES TO OX40 AND THEIR APPLICATION
CL2023000499A1 (en) Proteins comprising antigen-binding domains of hk2 and their uses.
CL2022003004A1 (en) ilt binding agents and methods for their use
UY37683A (en) MONOCLONAL ANTIBODY ANTI-PD-L1 MONOCLONAL
CL2022000096A1 (en) Anti-tigit antibodies and their application
DOP2023000158A (en) TRIESPECIFIC ANTIBODY TARGETED BCMA, GPRC5D, AND CD3
CL2022002488A1 (en) Materials and methods for the binding of siglec-3/cd33.
PE20201149A1 (en) HLA-A2 / WT1 BINDING ANTIBODIES
CR20220517A (en) Materials and methods for binding siglec-3/cd33
AR121578A1 (en) MATERIALS AND METHODS FOR THE BINDING OF IG-TYPE LECTIN BINDING TO SIALIC ACID
AR112758A1 (en) AGONIST ANTIBODIES BINDING HUMAN CD137, AND USES OF THE SAME
EA201990176A1 (en) ANTIBODIES TO TIM3 AND THEIR APPLICATION